Why is the Polynovo share price rising while other ASX 200 stocks are plummeting?

Despite most ASX companies being in the red today, the Polynovo Ltd (ASX: PNV) share price is rising.

During late afternoon trade, the medical device company’s shares are changing hands for $1.21, up 4.76%.

In comparison, the S&P/ASX 200 Index (ASX: XJO) is plummeting by 4.33% to 6,631 points.

Polynovo defies ASX market sell-off

Polynovo investors are shrugging off the wider market slump today.

The company hasn’t made any price-sensitive announcements since its third quarter trading update in early April.

However, insider buying action among senior Polynovo managers has likely propped up the share price and overall sentiment.

In particular, Polynovo chairperson David Williams made a series of purchases from the start of May totalling more than $5 million.

Not only did Williams take advantage of the share price weakness but he’s been averaging down his cost position.

In total, Williams now has more than 24.59 million Polynovo shares spread across a series of portfolios.

The number of buy-ins conducted tells us that Williams believes the company’s shares are trading at an attractive price. This seems to have resonated with investors, which could be why Polynovo is defying the ASX sell-off today.

It is worth nothing that at the start of May, Polynovo shares hit a 52-week low of 83.5 cents.

Polynovo share price summary

Since this time last year, the Polynovo share price has fallen by 56%.

Year-to-date it has fared better, but you’d still be looking at a loss of 25% if you invested at the start of 2022.

Based on today’s share price, Polynovo presides a market capitalisation of approximately $764.25 million.

The post Why is the Polynovo share price rising while other ASX 200 stocks are plummeting? appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#43B02A”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#43B02A”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• Why Australian Clinical Labs, Lake Resources, PolyNovo, and ResApp are rising
• These are the 10 most shorted ASX shares
• ASX 200 midday update: Magellan smashed, Liontown signs Tesla deal
• Appen and PolyNovo tumble after being kicked out of the ASX 200 along with these shares
• These are the 10 most shorted ASX shares

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended POLYNOVO FPO. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/9bYRJzk